Drug
Squaric Acid Dibutyl Ester
Squaric Acid Dibutyl Ester is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
200%(2 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
2
50%
Ph early_phase_1
1
25%
Ph phase_1
1
25%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Terminated(1)
Detailed Status
Not yet recruiting1
Terminated1
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (25.0%)
Phase 11 (25.0%)
Phase 22 (50.0%)
Trials by Status
not_yet_recruiting125%
terminated125%
recruiting125%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_2
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
NCT05535738
completedphase_1
Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)
NCT03661541
not_yet_recruitingearly_phase_1
SADBE for Congenital Melanocytic Nevi
NCT04999631
terminatedphase_2
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
NCT03521479
Clinical Trials (4)
Showing 4 of 4 trials
NCT05535738Phase 2
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
NCT03661541Phase 1
Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)
NCT04999631Early Phase 1
SADBE for Congenital Melanocytic Nevi
NCT03521479Phase 2
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4